Team

Bryant Moore, Ph.D.

Bryant Moore currently is Director, New Ventures and Partnerships, for Innovate Carolina at UNC-Chapel Hill. Bryant joined UNC-Chapel Hill in 2015 as Director, Strategic Partnerships in their Office of Technology Commercialization. Prior to UNC-Chapel Hill, he had more than 30 years of successful leadership and management roles in the medical device industry. His background includes experience in the clinical diagnostics, endoscopy and sports medicine, cardiology and ophthalmology medtech segments. Most of his experience was in the research and development and strategy areas for organizations with more than $1 billion in revenue.

His last industry role was global head of refractive research and development for Abbott Medical Optics, a division of Abbott Laboratories. Prior to Abbott, Bryant held several key leadership roles in Medtronic’s cardiac rhythm disease management business. He was vice president of external partnerships and technology assessment, having accountability for developing strategic partnerships with early-stage startups, universities and other external research organizations to ensure the business successfully developed relationships to acquire externally developed technologies to grow the product pipeline. Prior to this role, he held the positions of vice president of biotechnology and technology scouting, vice president of product development and technology, and vice president of applied technology and central engineering.

Prior to Medtronic, Bryant was worldwide vice president of research and development and  management board member for Smith and Nephew Endoscopy. Prior to Smith and Nephew, he worked for Johnson and Johnson, where he held several key leadership positions within their clinical diagnostics business. These positions were vice president of Assay R&D, vice president of research and development, director of technology and hemostasis R&D, manufacturing manager for immunoassay products and senior scientist. He was also a member of the management board of Ortho Diagnostic Systems. Prior to Johnson and Johnson, Bryant worked as manager of hemostasis for Organon Teknika, a division of Akzo Nobel. Bryant began his career as a scientist at DuPont. He also previously served as a member of the board of directors of Natus Medical (NASDAQ: NTUS) which was acquired by the Archimed Group.

He earned a bachelor’s degree in chemistry at North Carolina A&T State University and a PhD in biochemistry from UNC-Chapel Hill.